In another study, Mager et al. (2020) demonstrated through mouse experiments that the co-action of the genus Olsenella with certain commensal bacteria could further enhance the immunotherapeutic efficacy of CRC by increasing the efficacy of CTLA-4 antibodies. This evidence concerns the gene CTLA4 and colorectal carcinoma.